The inhibitory Notch ligand Delta-like protein 3 (DLL3) (6), a direct transcriptional target of the neuroendocrine transcription factor ASCL1 (7), is expressed specifically on the surface of neuroendocrine cancers, including SCLC (8). Here, DLL3 is linked to small cell lung carcinoma.